Oxford Finance Closes $50MM Facility For Superior Biologics
Oxford Finance served as co-lender and documentation agent in the closing of a $35 million term loan and a $15 revolving line of credit for Superior Biologics.
Oxford Finance served as co-lender and documentation agent in the closing of a $35 million term loan and a $15 revolving line of credit for Superior Biologics.
Oxford Finance has closed a unitranche $64 million term loan and a $7 million revolving line of credit with a subsidiary of Mid-Atlantic Health Care.
Joshua S. Brown joined the Oxford Finance healthcare lending team.
Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, closed an $8 million senior secured term loan with BiO2Medical.
MabVax Therapeutics Holdings closed on the first part of a financing agreement with Oxford Finance, a leading life sciences and healthcare lender.
Omeros Corporation has closed a $70 million non-dilutive senior credit facility with Oxford Finance and East West Bank.
Oxford Finance closed a $7.29 million senior secured term loan and a $1 million revolver with Birchwood Health Care Properties.
Oxford Finance said it closed a $13.95 million senior secured term loan with Continuum Healthcare.
Oxford Finance and Silicon Valley Bank announced the closing a $39.2 million credit facility encompassing a $35.2 million term loan and a $4 million revolver with SI-BONE.
Oxford Finance said it closed a $20 million senior secured term loan with Venus Concept.